A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment(SUPER-2)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

620

Participants

Timeline

Start Date

October 12, 2021

Primary Completion Date

June 15, 2023

Study Completion Date

August 13, 2023

Conditions
Type2 Diabetes
Interventions
BIOLOGICAL

supaglutide injection+metformin

supaglutide subcutaneous injection under RP3D dose combined with metformin treatment

OTHER

placebo+metformin

placebo subcutaneous injection combined with metformin treatment

Trial Locations (61)

Unknown

Beijing Boai Hospital, Beijing

Beijing Pinggu Hospital, Beijing

Emergency General Hospital, Beijing

Cangzhou Central Hospital, Cangzhou

Cangzhou Hospital of Integrated TCM-WM Hebei, Cangzhou

The Second Hospital of Jilin University, Changchun

First People's Hospital of Changde, Changde

Changsha Hopital Affiliated to Hunan University, Changsha

The Fourth Hospital of Changsha, Changsha

Chengdu Fifth People's Hospital, Chengdu

Chenzhou First People's Hospital, Chenzhou

Chongqing Ninth People's Hospital, Chongqing

Dalian Municipal Central Hospital, Dalian

Daqing People's Hospital, Daqing

Jilin Guowen Hospital, Gongzhuling

Handan First Hospital, Handan

The Fourth Affiliated Hospital of Harbin Medical University, Harbin

Heze Municipal Hospital, Heze

Huai'an First People's Hospital, Huai'an

Huai'an Second People's Hospital, Huai'an

Huizhou Central Hospital, Huizhou

Jilin People's Hospital, Jilin

Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan

Jincheng General Hospital, Jincheng

Jingzhou Central Hospital, Jingzhou

The Second Affiliated Hospital of Kunming Medical University, Kunming

The Second People's Hospital of Lianyungang, Lianyungang

Linfen People's Hospital, Linfen

First People's Hospital of Tancheng, Linyi

Liuzhou People's Hospital, Liuzhou

The First Affiliated Hospital of Henan University, Luoyang

Meihekou Central Hospital, Meihekou

Jiangxi Provincial People's Hospital, Nanchang

Nanjing First Hospital, Nanjing

Nanjing Jiangning Hospital, Nanjing

Sir Run Run Hospital of Nanjing Medical University, Nanjing

Nanyang First People's Hospital, Nanyang

Nanyang Second General Hospital, Nanyang

The First Affiliated Hospital of Nanyang Medical College, Nanyang

Puyang Oilfield General Hospital, Pujiang

The First Hospital of Qinhuangdao, Qinhuangdao

The First Hospital of Qiqihar, Qiqihar

Changhai Hospital, Shanghai

Huadong Hospital, Shanghai

Shanghai Pudong New Area People's Hospital, Shanghai

Shanghai Sixth People's Hospital Affiliated to Shanghai JiaoTong University, Shanghai

Shanghai Tongren Hospital, Shanghai

Siping Central Hospital, Siping

Second Hospital of Shanxi Medical University, Taiyuan

The Second Affiliated Hospital of Shandong First Medical University, Tanan

The Second Hospital of Tanjin Medical University, Tianjin

Tianjin Medical University General Hospital, Tianjing

Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Jiangyin People's Hospital, Wuxi

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

Xuzhou Cancer Hospital, Xuzhou

The Second People's Hospital of Yibin, Yibin

Yichun People's Hospital, Yichun

Yiyang Central Hospital, Yiyang

The Second Affiliated Hospital of Zhengzhou University, Zhengzhou

First People's Hospital of Zunyi, Zunyi

All Listed Sponsors
lead

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

OTHER

NCT04998032 - A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment(SUPER-2) | Biotech Hunter | Biotech Hunter